Literature DB >> 17094413

Evaluation of three mRNA markers for the detection of lymph node metastases.

Jennifer Berger1, Elisabeth Mueller-Holzner, Heidi Fiegl, Christian Marth, Guenter Daxenbichler.   

Abstract

The expressions of three mRNA markers were correlated with the results of extensive histopathological examination of a total of 290 axillary lymph nodes from 29 breast carcinoma patients. Included were two established markers for breast cancer (cytokeratin-19 and mammaglobin) and the novel marker DNA methyltransferase 3b (DNMT3b). DNMT3b was significantly overexpressed in breast cancer compared to normal breast tissue. The expression of the three markers in axillary lymph nodes was determined using quantitative real-time RT-PCR. DNMT3b expression showed a specificity of more than 99%, which was comparable to that of cytokeratin-19 and better than that of mammaglobin. The sensitivity of RT-PCR relative to histopathology was highest for cytokeratin-19 (96%), followed by DNMT3b (88%) and mammaglobin (68%). The overall agreement of histological and RT-PCR results was 96-99%. The results indicate that expression analysis of marker genes by quantitative RT-PCR can be a useful tool for lymph node diagnosis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17094413

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.

Authors:  Xiaxia Man; Qi Li; Baogang Wang; He Zhang; Songling Zhang; Ziyi Li
Journal:  Front Cell Dev Biol       Date:  2022-05-10

Review 2.  Human mammaglobin in breast cancer: a brief review of its clinical utility.

Authors:  Fawwaz Shakir Al Joudi
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

3.  Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis.

Authors:  Ana Monsalve-Lancheros; Milcíades Ibáñez-Pinilla; Sandra Ramírez-Clavijo
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.